MyBody-X angle on IgE Allergie Basis

MyBody-X's angle on IgE allergies suggests that genetic variants may influence individual susceptibility to allergic reactions. However, the evidence for direct, clinically actionable predictions from DNA tests is currently weak. IgE allergies are polygenic and heavily environment-dependent; even well-studied genes like FUT2 (secretor status, rs1047781) or SOD2 (antioxidant, rs4880) have only indirect and inconsistent associations with allergy risk. The provided context lacks specific studies on IgE allergies. Therefore, genetic testing for IgE allergies in the context of personalized medicine is not yet sufficiently validated. MyBody-X should clearly state that such tests do not replace diagnosis but may offer hints about possible predispositions. The benefit remains questionable until large, reproducible studies emerge. Safety note: If an IgE-mediated allergy is suspected, an allergen test by a physician (specific IgE, skin prick test) remains the gold standard.